When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen ...

A major discovery by Australian researchers of a key driver of prostate cancer could lead to the next generation of targeted ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Christian Edouard-Betsy was at work when his doctor called and asked him to meet immediately to discuss the results of a ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...